Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II randomized double-blind placebo-controlled study of HS-10506 in adults with insomnia disorder
CTR20240405Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10506 in Insomnia, sponsored by Hengrui Therapeutics. Started Feb 2024; status: completed.
02
Drugs
HS-10506
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20240405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240405.